Dental Care Clinics in Flushing, NY Accepting Medicare
127 Dental Care Clinics found. Showing 121 - 127
 Kyaw & Tan Dental Pc Clinic/Center - Dental Medicare: Not Enrolled in Medicare Practice Location: 4260 Main St, Flushing, NY 11355 Phone: 718-461-4678 |
Koam Dental, Pc Dentist Medicare: Not Enrolled in Medicare Practice Location: 3511 Farrington St, Flushing, NY 11354 Phone: 718-886-6677 Fax: 718-886-1413 |
Ruohong Jiang, Dds, Pllc Clinic/Center - Dental Medicare: Not Enrolled in Medicare Practice Location: 41-63 Bowne Street, Flushing, NY 11355 Phone: 718-762-0299 Fax: 718-762-0312 |
Wen Ta Fan Dds Pc Clinic/Center - Dental Medicare: Not Enrolled in Medicare Practice Location: 4231 Colden St Ste 204, Flushing, NY 11355 Phone: 718-539-9130 Fax: 718-539-9180 |
37th Ave Dental Care Pllc Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 13633 37th Ave Ste 4b, Flushing, NY 11354 Phone: 347-203-1771 |
Peter Lo Dmd, P.c. Clinic/Center - Dental Medicare: Not Enrolled in Medicare Practice Location: 13347 Sanford Ave Ste C1b, Flushing, NY 11355 Phone: 718-888-8828 |
Queensboro Dental Pc Clinic/Center - Dental Medicare: Not Enrolled in Medicare Practice Location: 15034 Union Tpke, Flushing, NY 11367 Phone: 718-380-0011 Fax: 718-820-0841 |
News Archive
CTI announces final pixantrone clinical trial design for treatment of DLBCL
Cell Therapeutics, Inc. today announced the final clinical trial design of a randomized pivotal trial of pixantrone for the treatment of diffuse large B-cell lymphoma following discussions with the U.S. Food and Drug Administration's Division of Hematologic Products.
Boston Scientific appoints Senior Vice President for its Cardiac Rhythm Management group
Boston Scientific Corporation (NYSE: BSX) today announced that Ken Stein, M.D., FACC, will join the Company as Senior Vice President and Associate Chief Medical Officer for its Cardiac Rhythm Management (CRM) group. Dr. Stein is currently the Associate Director of Clinical Cardiac Electrophysiology at Weill Cornell Medical Center and Associate Professor of Medicine at Cornell University.
Amarin completes enrollment in AMR101 Phase 3 MARINE clinical trial
Amarin Corporation plc, a clinical-stage biopharmaceutical company with a focus on cardiovascular disease, today announced that its MARINE trial, a Phase 3 clinical trial of AMR101, has completed patient enrollment and randomization into the treatment phase of this trial. The Company indicated that top line results from this trial are expected early in 2011, towards the early part of the range of guidance provided previously.
Regulators puzzling out what insurers must do under new health law
The Washington Post reports that regulators are "trying to resolve" which insurance plans must comply with the health law's new requirements. "In keeping with President Obama's promise that you can hold on to your insurance if you like it, the new law exempts existing health plans from many of its provisions. But the law leaves it to regulators to decide how much a health plan can change without giving up its grandfathered status."
› Verified 4 days ago